Preliminary results of pravastatin on non-hemorrhagic vertebral artery dissection: an exploratory randomized and controlled study.

BMC Neurol · 2025 · PMC12131487 · PMID 40461956

Europe PMC DOI

hedged sentences

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

borderline significanceP = .06so close (0.05 < p ≤ 0.1)

Morphologic changes in the early period (0–1 month) were more improved or resolved in the pravastatin group with a borderline significance (crude odds ratio: 7.500 [95% confidence interval: 0.921-64.047], P = .06).

also in 7,017 other papers

borderline significantno p-value reported

Conclusion Pravastatin had a borderline significant effect on the recovery of non-hemorrhage VAD with no additional adverse effects.

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.